Replies to post #204643 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

KravMD You need to be aware of Sustol APF530 Granisetron substantial delays year after year. The IND was submitted 7 years ago in May 2009

http://www.drugs.com/nda/apf530_121016.html

For some public unknown reason the FDA keeps wanting more data on Sustol APF530 Granisetron. The delays in 2016 are simply more of the same.

SequestOx has had FDA Priority Review designation which means that the FDA has all the data it needs to make a decision on or before Jul 14. 2016.